Entera Bio Ltd (ENTX):製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Entera Bio Ltd (ENTX) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C8178
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:17
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:イスラエル
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Entera Bio Ltd (Entera Bio) is a clinical-stage biopharmaceutical company that provides development and commercialization of a novel drug delivery platform for bone healing. The company develops novel drug delivery platform for oral delivery of large molecule protein active pharmaceutical ingredients. It conducts clinical trials of three candidate drugs based on applying Entera’s technology to teriparatide for the treatment of hypoparathyroidism, osteoporosis, bone healing, and others. The company also provides clinical trial programs and orphan drug designation for hypoparathyroidism. Entera Bio is headquartered in Jerusalem, Israel.

Entera Bio Ltd (ENTX) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Entera Bio Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Entera Bio Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Entera Bio Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Entera Bio Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Entera Bio Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Entera Bio Ltd, Pharmaceuticals & Healthcare, Deal Details 10
Venture Financing 10
Entera Bio Raises USD2 Million in Venture Financing 10
Entera Bio Plans to Raise USD10 Million in Venture Financing 11
Equity Offering 12
Entera Bio Raises USD11 Million in IPO of Shares 12
Entera Files Registration Statement to Raise Funds through Public Offering of Shares 13
Entera Bio Ltd – Key Competitors 14
Entera Bio Ltd – Key Employees 15
Entera Bio Ltd – Locations And Subsidiaries 16
Head Office 16
Appendix 17
Methodology 17
About GlobalData 17
Contact Us 17
Disclaimer 17

List of Tables
Entera Bio Ltd, Pharmaceuticals & Healthcare, Key Facts, 2016 2
Entera Bio Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Entera Bio Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Entera Bio Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Entera Bio Ltd, Deals By Therapy Area, 2012 to YTD 2018 8
Entera Bio Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Entera Bio Raises USD2 Million in Venture Financing 10
Entera Bio Plans to Raise USD10 Million in Venture Financing 11
Entera Bio Raises USD11 Million in IPO of Shares 12
Entera Files Registration Statement to Raise Funds through Public Offering of Shares 13
Entera Bio Ltd, Key Competitors 14
Entera Bio Ltd, Key Employees 15

List of Figures
Entera Bio Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Entera Bio Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Entera Bio Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Entera Bio Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Entera Bio Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Entera Bio Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Entera Bio Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Entera Bio Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[Entera Bio Ltd (ENTX):製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Activision Blizzard, Inc.:企業の戦略・SWOT・財務情報
    Activision Blizzard, Inc. - Strategy, SWOT and Corporate Finance Report Summary Activision Blizzard, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • ConocoPhillips (COP):電力:M&Aディール及び事業提携情報
    Summary ConocoPhillips is an independent upstream oil and gas company. The company explore for, produce, transport and market crude oil, bitumen, natural gas, liquefied natural gas (LNG) and natural gas liquids across the world. It has assets across North America, Europe, Asia and Australia. Its ass …
  • Peloton Therapeutics Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Peloton Therapeutics Inc (Peloton) is a clinical-stage pharmaceutical company that develops oral medicines and novel therapies for oncology. Its portfolio of pipeline products includes PT2977, PT2567 and PT2385. The company develops its products for the treatment of pulmonary arterial hypert …
  • Impol Seval A.D. Sevojno
    Impol Seval A.D. Sevojno - Strategy, SWOT and Corporate Finance Report Summary Impol Seval A.D. Sevojno - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Burgan Bank Sak:企業の戦略・SWOT・財務分析
    Burgan Bank Sak - Strategy, SWOT and Corporate Finance Report Summary Burgan Bank Sak - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Intercept Pharmaceuticals Inc (ICPT):企業の財務・戦略的SWOT分析
    Intercept Pharmaceuticals Inc (ICPT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Bank of Cyprus Public Company Ltd:企業のM&A・事業提携・投資動向
    Bank of Cyprus Public Company Ltd - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Bank of Cyprus Public Company Ltd Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mer …
  • The Chemours Company LLC:企業の戦略・SWOT・財務情報
    The Chemours Company LLC - Strategy, SWOT and Corporate Finance Report Summary The Chemours Company LLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Microsoft Corporation (MSFT):企業の財務・戦略的SWOT分析
    Microsoft Corporation (MSFT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Celldex Therapeutics, Inc.:企業のM&A・事業提携・投資動向
    Celldex Therapeutics, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Celldex Therapeutics, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acqui …
  • CryoLife Inc (CRY):医療機器:M&Aディール及び事業提携情報
    Summary CryoLife Inc (CryoLife) is a provider of biosurgical devices and implantable living tissues for cardiac and vascular surgical procedures. The company’s portfolio enlists preserved human cardiac allografts, vascular allografts, surgical adhesives and sealants, heart valves, carbon dioxide dif …
  • Hunt Oil Co:石油・ガス:M&Aディール及び事業提携情報
    Summary Hunt Oil Co (Hunt Oil), a subsidiary Hunt Consolidated, Inc., is an independent upstream company. It carries out exploration, production and development of oil and natural gas. In the US, it has acreage and active programs in the Williston Basin (Bakken) of North Dakota, the Permian Basin of …
  • Cevec Pharmaceuticals GmbH:企業のM&A・事業提携・投資動向
    Cevec Pharmaceuticals GmbH - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Cevec Pharmaceuticals GmbH Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acqui …
  • FedEx Corporation (FDX):企業の財務・戦略的SWOT分析
    FedEx Corporation (FDX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • Tech Mahindra Limited:企業の戦略・SWOT・財務分析
    Tech Mahindra Limited - Strategy, SWOT and Corporate Finance Report Summary Tech Mahindra Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • China Resources Land Limited:戦略・SWOT・企業財務分析
    China Resources Land Limited - Strategy, SWOT and Corporate Finance Report Summary China Resources Land Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Arcadia Group Limited:企業の戦略・SWOT・財務分析
    Arcadia Group Limited - Strategy, SWOT and Corporate Finance Report Summary Arcadia Group Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • ExpressJet Airlines, Inc:企業の戦略・SWOT・財務情報
    ExpressJet Airlines, Inc - Strategy, SWOT and Corporate Finance Report Summary ExpressJet Airlines, Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • New York Power Authority:企業の戦略・SWOT・財務分析
    New York Power Authority - Strategy, SWOT and Corporate Finance Report Summary New York Power Authority - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • BEKB | BCBE Private Banking:企業の戦略・SWOT・財務情報
    BEKB | BCBE Private Banking - Strategy, SWOT and Corporate Finance Report Summary BEKB | BCBE Private Banking - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆